ARCHIVES

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Funding Opportunity.

July 12, 2002

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986